Glioblastomas are aggressive brain tumors with dismal prognosis. One of the main bottlenecks for developing more effective therapies for glioblastoma stems from their histologic and molecular heterogeneity. leading to distinct tumor microenvironments and disease phenotypes. Effectively characterizing these features would improve the clinical management of glioblastoma. https://ozqntfrdimaw5q.timeblog.net/70688501/Методы-влияния-нa-упрaвление-рискaми-в-сельском-хозяйстве-aуыл-шaруaшылығындa-тәуекелділіктерді-бaсқaруғa-әсер-ететін-әдістер